Form 4 for SLSN SOLESENCE, INC.
Accepted 2024-11-05 00:00:00 ET · period of report 2024-10-29 · accession 0000950170-24-121444 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-11-05 | 2024-10-29 | SLSN | WHITMORE R JANET | Dir | P - Purchase | $0.8365 | +45.3K | 2.01M | +2% | +$37.9K |
| DM | 2024-11-05 | 2024-10-29 | SLSN | WHITMORE R JANET | Dir | M - OptEx | $0.9123 | -58.7K | 0 | -100% | -$53.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-29 | P | A | 6,667 | $0.45 | 2,042,476 | D | — | — | |
| 2 | Common | Common Stock | 2024-10-29 | P | A | 6,666 | $1.17 | 2,049,142 | D | — | — | |
| 3 | Common | Common Stock | 2024-10-29 | P | A | 10,000 | $0.68 | 2,025,809 | D | — | — | |
| 4 | Common | Common Stock | 2024-10-29 | P | A | 2,000 | $0.99 | 2,015,809 | D | — | — | |
| 5 | Common | Common Stock | 2024-10-29 | P | A | 10,000 | $0.82 | 2,035,809 | D | — | — | |
| 6 | Common | Common Stock | 2024-10-29 | P | A | 2,000 | $0.84 | 2,011,809 | D | — | — | |
| 7 | Common | Common Stock | 2024-10-29 | P | A | 2,000 | $1.18 | 2,009,809 | D | — | — | |
| 8 | Common | Common Stock | 2024-10-29 | P | A | 2,000 | $1.05 | 2,007,809 | D | — | — | |
| 9 | Common | Common Stock | 2024-10-29 | P | A | 2,000 | $0.9 | 2,005,809 | D | — | — | |
| 10 | Common | Common Stock | 2024-10-29 | P | A | 2,000 | $1.10 | 2,013,809 | D | — | — | |
| 11 | Derivative | Common Stock (Right to Buy) | 2024-10-29 | M | D | 2,000 | $1.18 | 0 | D | $1.18 · 2017-11-17 to 2026-11-17 | 2,000 Common Stock | (F4) The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. Two-thousand shares were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85. 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. |
| 12 | Derivative | Common Stock (Right to Buy) | 2024-10-29 | M | D | 2,000 | $1.05 | 0 | D | $1.05 · 2017-11-17 to 2026-11-17 | 2,000 Common Stock | (F4) The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. Two-thousand shares were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85. 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. |
| 13 | Derivative | Common Stock (Right to Buy) | 2024-10-29 | M | D | 2,000 | $0.9 | 0 | D | $0.9 · 2017-11-17 to 2026-11-17 | 2,000 Common Stock | (F4) The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. Two-thousand shares were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85. 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. |
| 14 | Derivative | Common Stock (Right to Buy) | 2024-10-29 | M | D | 2,000 | $1.10 | 0 | D | $1.10 · 2017-11-17 to 2026-11-17 | 2,000 Common Stock | (F4) The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. Two-thousand shares were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85. 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. |
| 15 | Derivative | Common Stock (Right to Buy) | 2024-10-29 | M | D | 2,000 | $0.84 | 0 | D | $0.84 · 2017-11-17 to 2026-11-17 | 2,000 Common Stock | (F4) The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. Two-thousand shares were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85. 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. |
| 16 | Derivative | Common Stock (Right to Buy) | 2024-10-29 | M | D | 10,000 | $0.68 | 0 | D | $0.68 · 2018-02-21 to 2027-02-21 | 10,000 Common Stock | (F5) Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. |
| 17 | Derivative | Common Stock (Right to Buy) | 2024-10-29 | M | D | 10,000 | $0.82 | 0 | D | $0.82 · 2019-05-23 to 2028-05-23 | 10,000 Common Stock | (F5) Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. |
| 18 | Derivative | Common Stock (Right to Buy) | 2024-10-29 | M | D | 6,667 | $0.45 | 0 | D | $0.45 · 2021-06-18 to 2027-06-18 | 6,667 Common Stock | (F5) Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. |
| 19 | Derivative | Common Stock (Right to Buy) | 2024-10-29 | M | D | 20,000 | $1.17 | 13,334 | D | $1.17 · 2023-12-20 to 2029-12-20 | 6,667 Common Stock | (F5) Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. |
| 20 | Derivative | Common Stock (Right to Buy) | 2024-10-29 | M | D | 2,000 | $0.99 | 0 | D | $0.99 · 2017-11-17 to 2026-11-17 | 2,000 Common Stock | (F4) The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. Two-thousand shares were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85. 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. |